Short-term EAE vaccine delay and supply challenge - Veterinary Practice
Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×

Short-term EAE vaccine delay and supply challenge

To avoid stock challenges there will be a temporary delay of the EAE vaccine Cevac Chlamydia towards the end of the main vaccination season

While many farmers have heeded recommendation from their vet to vaccinate ewes early for enzootic abortion of ewes (EAE) to avoid stock challenges, there will unfortunately be a temporary delay of the EAE vaccine Cevac Chlamydia towards the end of the main vaccination season.

This is due to delays in the manufacturing and distribution process, and it is anticipated to be a delay of only two to three weeks.

Ceva Animal Health, the manufacturer of the EAE vaccine, understands the significance of vaccinations in maintaining the health and welfare of livestock and the company deeply regrets any inconvenience caused to its valued sheep farmers during this period.

The company’s primary goal has always been to ensure a stable and sufficient supply of vaccines and it is working tirelessly to resolve this challenge.

Commenting on the EAE vaccine supply challenge and delay, Roy Geary, regional director for Northern Europe (including the UK) at Ceva Animal Health, says: “The manufacturing of vaccines is a complex process that involves stringent quality control measures and adherence to regulatory guidelines.

“There have been unforeseen manufacturing issues at our production facilities, which have temporarily affected the ability to meet the demands of the UK sheep market within the main seasonal vaccination period for EAE.

“As a responsible provider, we are actively addressing these issues to minimise the impact on customers.

“In collaboration with relevant stakeholders, we have implemented comprehensive contingency plans to optimise the manufacturing and distribution process.

“Our dedicated team is working closely with our partners to resolve the challenges and restore normal supply levels as soon as possible.

“The EAE vaccine challenge is being treated with the utmost urgency, and we are actively exploring alternative sourcing options to supplement the existing supply chain.

“We anticipate that the delay in supply will be resolved in the near future, however we recognise that for some farmers the supply will arrive too late for them to use.

“We encourage all farmers to consult their vet and explore alternative means of safeguarding the health of their flocks during this period.

“We recommend implementing robust biosecurity measures and adhering to existing vaccination protocols for other preventable diseases to ensure the overall wellbeing of livestock.

“We will provide vet practices and the wider industry with regular updates as we progress toward a resolution and return to normal supply levels.”

For further information, please contact your Ceva territory manager or Ceva Animal Health on 01628 334056.

Have you heard about our
IVP Membership?

A wide range of veterinary CPD and resources by leading veterinary professionals.

Stress-free CPD tracking and certification, you’ll wonder how you coped without it.

Discover more